HEART AND VESSELS INVOLVEMENT IN THE ANTIPHOSPHOLIPID SYNDROME
Abstract
An investigation was made into the clinical features of cardiac-vascular system of 200 patients with antiphospholipid syndrome (APS): 61 patients had PAPS (primary APS), 139 patients had SAPS (secondary APS), associated with systemic lupus erythematosus (SLE) (115 cases) or Sharp syndrome (24 cases). The data obtained indicate certain differences between PAPS and SAPS. Cardiac valve alteration, mainly of mitral valve, with either or insufficiency, stenosis, fibrosis, calcinosis and vegetations were suggestive of PAPS. SAPS was featured by more rare cardiac valve alterations (concerning mainly mitral valve); and arterial hypertension (50 per cent cases) of, probably, renal origin, which caused cardiomyopathy. These results may regard as differential-diagnostic criteria in clinical practice.
About the Authors
N. N. Chapayeva
Новосибирская государственная медицинская академия МЗРФ, Новосибирск
Russian Federation
Russian Federation
A. A. Demin
Новосибирская государственная медицинская академия МЗРФ, Новосибирск
Russian Federation
Russian Federation
References
1. Насонов Е.Л., Алекберова З.С., Александрова Л.З. и др. Антитела к кардиолипину: метод определения и клиническое значение // Клин. мед. – 1987. - № 11. – С. 100 – 104.
2. Насонов Е.Л. Антифосфолипидный синдром: клиническая и иммунологическая характеристика // Клин. мед. – 1989. - № 1. – С. 5 – 13.
3. Насонов Е.Л., Карпов Ю.А., Алекберова З.С. и др. Антифосфолипидный синдром: кардиологические аспекты // Тер. архив. – 1993. - № 11. – С. 80 – 86.
4. Насонов Е.Л., Саложин К.В., Фомичева О.А. и др. Антиэндотелиальные антитела и поражение клапанов сердца при антифосфолипидном синдроме: анализ патогенетических механизмов // Клин. мед. – 1997. - № 2. – С. 17 – 22.
5. Насонов Е.Л., Алекберова З.С., Калашникова Л.А. и др. Антифосфолипидный синдром (синдром Hughes): 10 лет изучения в России // Клин. мед. – 1998. - № 2. – С. 4 – 11.
6. Попкова Т.В., Покровский С.Н., Алекберова З.С. и др. Липопротеин(а) при системной красной волчанке // Клин. мед. – 1998. – № 1. – С. 5 – 10.
7. Hughes G.R.V., Gharavi A.E., Harris A.E. The anticardiolipin syndrome // J. Rheum. – 1986. – Vol. 13. – P. 486 – 489.
8. Hughes G.R.V. The antiphospholipid syndrome: ten years on // Lancet. – 1993. – Vol. 324. – P. 341 – 344.
9. Love P.E., Santoro S.A. Antiphospholipid antibodies: anticardiolipin and lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders // Ann. Intern. Med. – 1990. – Vol. 112. – P. 628 – 698.
10. Vianna J.L., Khamashta M.A., Ordi-Ros J. et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients // Amer. J. Med. – 1994. – Vol. 96. – P. 3 – 9.
11. Tan E.M., Cohen A.S., Fries J.F. et al. The 1982 revised criteria for classification of systemic lupuc erythematosus // Arthr. Rheum. – 1982. – Vol. 25. – P. 1271 – 1277.
Review
For citations:
Chapayeva N.N., Demin A.A. HEART AND VESSELS INVOLVEMENT IN THE ANTIPHOSPHOLIPID SYNDROME. Russian Journal of Cardiology. 2001;(3):25-28. (In Russ.)
Views:
945
Email this article 